NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivo.
Saved in:
| Title: | NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivo. |
|---|---|
| Authors: | Namoto K; Biomedical Research, Novartis Pharma AG, Basel, Switzerland. Electronic address: kenji.namoto@novartis.com., Baader C; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland; University of Basel, Basel, Switzerland., Orsini V; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Landshammer A; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Breuer E; University Hospital Zurich (USZ), Zurich, Switzerland., Dinh KT; German Cancer Research Center (DKFZ) Heidelberg, Research Group Experimental Hepatology, Inflammation and Cancer, Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Ungricht R; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Pikiolek M; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Laurent S; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Lu B; Biomedical Research, Novartis Pharma AG, Cambridge, MA, USA., Aebi A; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Schönberger K; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Vangrevelinghe E; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Evrova O; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Sun T; Biomedical Research, Novartis Pharma AG, Basel, Switzerland; Division of Liver Diseases, Institute for Regenerative Medicine, Department of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Annunziato S; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Lachal J; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Redmond E; Biomedical Research, Novartis Pharma AG, Cambridge, MA, USA., Wang L; Biomedical Research, Novartis Pharma AG, Cambridge, MA, USA., Wetzel K; Biomedical Research, Novartis Pharma AG, Cambridge, MA, USA., Capodieci P; Biomedical Research, Novartis Pharma AG, Cambridge, MA, USA., Turner J; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Schutzius G; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Unterreiner V; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Trunzer M; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Buschmann N; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Behnke D; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Machauer R; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Scheufler C; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Parker CN; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Ferro M; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Grevot A; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Beyerbach A; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Lu WY; University of Edinburgh, Center for Inflammation Research, Edinburgh, UK., Forbes SJ; University of Edinburgh, Center for Regenerative Medicine, Edinburgh, UK., Wagner J; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Bouwmeester T; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Liu J; Biomedical Research, Novartis Pharma AG, La Jolla, CA, USA., Sohal B; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Sahambi S; Biomedical Research, Novartis Pharma AG, Cambridge, MA, USA., Greenbaum LE; Biomedical Research, Novartis Pharma AG, East Hanover, NJ, USA., Lohmann F; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Hoppe P; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Cong F; Biomedical Research, Novartis Pharma AG, Cambridge, MA, USA., Sailer AW; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Ruffner H; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Glatthar R; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Humar B; University Hospital Zurich (USZ), Zurich, Switzerland., Clavien PA; University Hospital Zurich (USZ), Zurich, Switzerland., Dill MT; German Cancer Research Center (DKFZ) Heidelberg, Research Group Experimental Hepatology, Inflammation and Cancer, Heidelberg, Germany; Department of Gastroenterology, Infectious Diseases and Intoxication, Heidelberg University Hospital, Heidelberg, Germany., George E; Biomedical Research, Novartis Pharma AG, Cambridge, MA, USA., Maibaum J; Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Liberali P; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland; University of Basel, Basel, Switzerland., Tchorz JS; Biomedical Research, Novartis Pharma AG, Basel, Switzerland. Electronic address: jan.tchorz@novartis.com. |
| Source: | Cell stem cell [Cell Stem Cell] 2024 Apr 04; Vol. 31 (4), pp. 554-569.e17. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101311472 Publication Model: Print Cited Medium: Internet ISSN: 1875-9777 (Electronic) Linking ISSN: 18759777 NLM ISO Abbreviation: Cell Stem Cell Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38579685 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivo. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Namoto+K%22">Namoto K</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland. Electronic address: kenji.namoto@novartis.com.<br /><searchLink fieldCode="AU" term="%22Baader+C%22">Baader C</searchLink>; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland; University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Orsini+V%22">Orsini V</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Landshammer+A%22">Landshammer A</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Breuer+E%22">Breuer E</searchLink>; University Hospital Zurich (USZ), Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dinh+KT%22">Dinh KT</searchLink>; German Cancer Research Center (DKFZ) Heidelberg, Research Group Experimental Hepatology, Inflammation and Cancer, Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Ungricht+R%22">Ungricht R</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pikiolek+M%22">Pikiolek M</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Laurent+S%22">Laurent S</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lu+B%22">Lu B</searchLink>; Biomedical Research, Novartis Pharma AG, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Aebi+A%22">Aebi A</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schönberger+K%22">Schönberger K</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Vangrevelinghe+E%22">Vangrevelinghe E</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Evrova+O%22">Evrova O</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sun+T%22">Sun T</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland; Division of Liver Diseases, Institute for Regenerative Medicine, Department of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Annunziato+S%22">Annunziato S</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lachal+J%22">Lachal J</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Redmond+E%22">Redmond E</searchLink>; Biomedical Research, Novartis Pharma AG, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Biomedical Research, Novartis Pharma AG, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wetzel+K%22">Wetzel K</searchLink>; Biomedical Research, Novartis Pharma AG, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Capodieci+P%22">Capodieci P</searchLink>; Biomedical Research, Novartis Pharma AG, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Turner+J%22">Turner J</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schutzius+G%22">Schutzius G</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Unterreiner+V%22">Unterreiner V</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Trunzer+M%22">Trunzer M</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Buschmann+N%22">Buschmann N</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Behnke+D%22">Behnke D</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Machauer+R%22">Machauer R</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Scheufler+C%22">Scheufler C</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Parker+CN%22">Parker CN</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ferro+M%22">Ferro M</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Grevot+A%22">Grevot A</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Beyerbach+A%22">Beyerbach A</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lu+WY%22">Lu WY</searchLink>; University of Edinburgh, Center for Inflammation Research, Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Forbes+SJ%22">Forbes SJ</searchLink>; University of Edinburgh, Center for Regenerative Medicine, Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Wagner+J%22">Wagner J</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bouwmeester+T%22">Bouwmeester T</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Liu+J%22">Liu J</searchLink>; Biomedical Research, Novartis Pharma AG, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Sohal+B%22">Sohal B</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sahambi+S%22">Sahambi S</searchLink>; Biomedical Research, Novartis Pharma AG, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Greenbaum+LE%22">Greenbaum LE</searchLink>; Biomedical Research, Novartis Pharma AG, East Hanover, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Lohmann+F%22">Lohmann F</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hoppe+P%22">Hoppe P</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Cong+F%22">Cong F</searchLink>; Biomedical Research, Novartis Pharma AG, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sailer+AW%22">Sailer AW</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ruffner+H%22">Ruffner H</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Glatthar+R%22">Glatthar R</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Humar+B%22">Humar B</searchLink>; University Hospital Zurich (USZ), Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Clavien+PA%22">Clavien PA</searchLink>; University Hospital Zurich (USZ), Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dill+MT%22">Dill MT</searchLink>; German Cancer Research Center (DKFZ) Heidelberg, Research Group Experimental Hepatology, Inflammation and Cancer, Heidelberg, Germany; Department of Gastroenterology, Infectious Diseases and Intoxication, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22George+E%22">George E</searchLink>; Biomedical Research, Novartis Pharma AG, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Maibaum+J%22">Maibaum J</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Liberali+P%22">Liberali P</searchLink>; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland; University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tchorz+JS%22">Tchorz JS</searchLink>; Biomedical Research, Novartis Pharma AG, Basel, Switzerland. Electronic address: jan.tchorz@novartis.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101311472%22">Cell stem cell</searchLink> [Cell Stem Cell] 2024 Apr 04; Vol. 31 (4), pp. 554-569.e17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101311472 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1875-9777 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218759777%22">18759777 </searchLink><i>NLM ISO Abbreviation: </i>Cell Stem Cell <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38579685 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.stem.2024.03.003 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 554 Titles: – TitleFull: NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivo. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Namoto K – PersonEntity: Name: NameFull: Baader C – PersonEntity: Name: NameFull: Orsini V – PersonEntity: Name: NameFull: Landshammer A – PersonEntity: Name: NameFull: Breuer E – PersonEntity: Name: NameFull: Dinh KT – PersonEntity: Name: NameFull: Ungricht R – PersonEntity: Name: NameFull: Pikiolek M – PersonEntity: Name: NameFull: Laurent S – PersonEntity: Name: NameFull: Lu B – PersonEntity: Name: NameFull: Aebi A – PersonEntity: Name: NameFull: Schönberger K – PersonEntity: Name: NameFull: Vangrevelinghe E – PersonEntity: Name: NameFull: Evrova O – PersonEntity: Name: NameFull: Sun T – PersonEntity: Name: NameFull: Annunziato S – PersonEntity: Name: NameFull: Lachal J – PersonEntity: Name: NameFull: Redmond E – PersonEntity: Name: NameFull: Wang L – PersonEntity: Name: NameFull: Wetzel K – PersonEntity: Name: NameFull: Capodieci P – PersonEntity: Name: NameFull: Turner J – PersonEntity: Name: NameFull: Schutzius G – PersonEntity: Name: NameFull: Unterreiner V – PersonEntity: Name: NameFull: Trunzer M – PersonEntity: Name: NameFull: Buschmann N – PersonEntity: Name: NameFull: Behnke D – PersonEntity: Name: NameFull: Machauer R – PersonEntity: Name: NameFull: Scheufler C – PersonEntity: Name: NameFull: Parker CN – PersonEntity: Name: NameFull: Ferro M – PersonEntity: Name: NameFull: Grevot A – PersonEntity: Name: NameFull: Beyerbach A – PersonEntity: Name: NameFull: Lu WY – PersonEntity: Name: NameFull: Forbes SJ – PersonEntity: Name: NameFull: Wagner J – PersonEntity: Name: NameFull: Bouwmeester T – PersonEntity: Name: NameFull: Liu J – PersonEntity: Name: NameFull: Sohal B – PersonEntity: Name: NameFull: Sahambi S – PersonEntity: Name: NameFull: Greenbaum LE – PersonEntity: Name: NameFull: Lohmann F – PersonEntity: Name: NameFull: Hoppe P – PersonEntity: Name: NameFull: Cong F – PersonEntity: Name: NameFull: Sailer AW – PersonEntity: Name: NameFull: Ruffner H – PersonEntity: Name: NameFull: Glatthar R – PersonEntity: Name: NameFull: Humar B – PersonEntity: Name: NameFull: Clavien PA – PersonEntity: Name: NameFull: Dill MT – PersonEntity: Name: NameFull: George E – PersonEntity: Name: NameFull: Maibaum J – PersonEntity: Name: NameFull: Liberali P – PersonEntity: Name: NameFull: Tchorz JS IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 04 Text: 2024 Apr 04 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1875-9777 Numbering: – Type: volume Value: 31 – Type: issue Value: 4 Titles: – TitleFull: Cell stem cell Type: main |
| ResultId | 1 |